| Literature DB >> 35301404 |
A Kasielska-Trojan1, J T Manning2, M Jabłkowski3, J Białkowska-Warzecha3, A L Hirschberg4, B Antoszewski5.
Abstract
COVID-19 presents with mild symptoms in the majority of patients but in a minority it progresses to acute illness and hospitalization. Here we consider whether markers for prenatal sex hormones and postnatal stressors on developmental instability, i.e. digit ratios and their directional and unsigned asymmetries, are predictive of hospitalization. We focus on six ratios: 2D:3D; 2D:4D; 2D:5D; 3D:4D; 3D:5D; 4D:5D and compare hospitalized patient and control means for right, and left ratios, directional asymmetries (right-left) and unsigned asymmetries [|(right-left)|]. There were 54 patients and 100 controls. We found (i) patients differed in their digit ratios from controls (patients > controls) in all three ratios that included 5D (2D:5D, 3D:5D and 4D:5D) with small to medium effect sizes (d = 0.3 to 0.64), (ii) they did not differ in their directional asymmetries, and (iii) patients had greater |(right-left)| asymmetry than controls for 2D:4D (d = .74) , and all ratios that included 5D; 2D:5D (d = 0.66), 3D:5D (d = .79), 4D:5D (d = 0.47). The Composite Asymmetry of the two largest effects (2D:4D + 3D:5D) gave a patient and control difference with effect size d = 1.04. All patient versus control differences were independent of sex. We conclude that digit ratio patterns differ between patients and controls and this was most evident in ratios that included 5D. Large |(right-left)| asymmetries in the patients are likely to be a marker for postnatal stressors resulting in developmental perturbations and for potential severity of COVID-19.Entities:
Mesh:
Year: 2022 PMID: 35301404 PMCID: PMC8931101 DOI: 10.1038/s41598-022-08646-7
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Characteristics of patients hospitalized because of Covid-19.
| n (%) | Men (n = 28) | Women (n = 26) | All (n = 54) |
|---|---|---|---|
| Age [years] | 54.7 ± 14.7 | 59.3 ± 18.2 | 56.9 ± 16.5 |
| BMI [kg/m2] | 30.3 | 30.4 | 30.3 |
| Dyspnoea | 16 (57.1) | 18 (69.2) | 34 (63) |
| Cough | 19 (67.8) | 20 (76.9) | 39 (72.2) |
| Fever | 21 (75) | 24 (92.3) | 45 (83.3) |
| Fatigue | 18 (64.3) | 22 (84.6) | 40 (74.1) |
| Loss of smell and taste | 1 (3.6) | 3 (11.5) | 4 (7.4) |
| Other/subclinical | 4 (14.3) | – | 4 (7.4) |
| Severity [mean] ( Likert scale 1–4) | 2.2 | 1.64 | 1.9 |
| Length of: hospital stay/oxygen therapy [mean, days] | 15.8/8.2 | 14.6/5.1 | 14.9/7.8 |
| Hypertension | 9 (32.1) | 16 (61.5) | 25 (46.3) |
| Ischaemic heart disease | 7 (25) | 9 (34.6) | 16 (29.6) |
| Diabetes mellitus | 3 (10.7) | 5 (19.2) | 8 (14.8) |
| Lung disorder (asthma, COPD) | 2 (7.1) | 2 (7.7) | 4 (7.4) |
| Thyroid disorders | 2 (7.1) | 1 (3.8) | 3 (5.6) |
| Other (cancer, hematologic, autoimmune disease) | 3 (10.7) | 3 (11.5) | 6 (11.1) |
| Smoking/ex-smoking | 8 (28.6%)/12 (42.8%) | 2 (7.7%)/6 (23.1%) | 10 (17.9)/18 (33.3) |
Technical error measurement (TEM) and the coefficient of reliability for raw measurements (R) for ratios and for R–L and |R–L| of six ratios for observer 1.
| Intra-observer Reliability | TEM | R (%) | ICC (%) |
|---|---|---|---|
| 2D3D R 1 vs. 2 | 0.005 | 97.89 | 97.91 |
| 2D3D L 1 vs. 2 | 0.009 | 95.61 | 95.65 |
| 2D4D R 1 vs. 2 | 0.004 | 99.41 | 99.42 |
| 2D4D L 1 vs. 2 | 0.004 | 99.63 | 99.63 |
| 2D5D R 1 vs. 2 | 0.009 | 99.66 | 99.66 |
| 2D5D L 1 vs. 2 | 0.012 | 98.91 | 98.92 |
| 3D4D R 1 vs. 2 | 0.006 | 98.18 | 98.19 |
| 3D4D L 1 vs. 2 | 0.009 | 96.07 | 96.11 |
| 3D5D R 1 vs. 2 | 0.011 | 99.52 | 99.52 |
| 3D5D L 1 vs. 2 | 0.0110 | 98.77 | 98.78 |
| 4D5D R 1 vs. 2 | 0.008 | 99.43 | 99.44 |
| 4D5D L 1 vs. 2 | 0.011 | 97.43 | 97.46 |
| 2D3D R1–L1 vs. R2–L2 | 0.0100 | 99.88 | 99.88 |
| 2D3D |R1–L1| vs. |R2–L2| | 0.0096 | 99.86 | 99.87 |
| 2D4D R1–L1 vs. R2–L2 | 0.0053 | 99.97 | 99.97 |
| 2D4D |R1–L1| vs. |R2–L2| | 0.0052 | 99.96 | 99.96 |
| 2D5D R1–L1 vs. R2–L2 | 0.0138 | 99.89 | 99.89 |
| 2D5D |R1–L1| vs. |R2–L2| | 0.0122 | 99.88 | 99.88 |
| 3D4D R1–L1 vs. R2–L2 | 0.0111 | 99.89 | 99.89 |
| 3D4D |R1–L1| vs. |R2–L2| | 0.0091 | 99.91 | 99.91 |
| 3D5D R1–L1 vs. R2–L2 | 0.0148 | 99.89 | 99.89 |
| 3D5D |R1–L1| vs. |R2–L2| | 0.0143 | 99.87 | 99.87 |
| 4D5D R1–L1 vs. R2–L2 | 0.0126 | 99.90 | 99.90 |
| 4D5D |R1–L1| vs. |R2–L2| | 0.0120 | 99.89 | 99.89 |
Patient and control means and SD’s for six digit ratios (2D:3D; 2D:4D; 2D:5D;3D:4D; 3D:5D; 4D:5D) and their signed and unsigned asymmetries.
| Patients | Controls | |||||||
|---|---|---|---|---|---|---|---|---|
| mean | SD | mean | SD | |||||
| Right | 51 | 0.89 | 0.036 | 100 | 0.900 | 0.035 | 0.114 | − 0.27 |
| Left | 52 | 0.897 | 0.044 | 99 | 0.897 | 0.038 | 0.987 | 0 |
| R–L | 49 | − 0.003 | 0.041 | 99 | 0.003 | 0.037 | 0.403 | − 0.14 |
| |R–L|* | 49 | 0.033 | 0.024 | 99 | 0.027 | 0.025 | 0.164 | 0.21 |
| Right | 51 | 0.962 | 0.054 | 100 | 0.969 | 0.046 | 0.386 | − 0.15 |
| Left | 52 | 0.968 | 0.067 | 100 | 0.974 | 0.042 | 0.583 | − 0.1 |
| R–L | 49 | − 0.005 | 0.065 | 100 | − 0.005 | 0.039 | 0.95 | − 0.01 |
| |R–L|* | 49 | 0.053 | 0.037 | 100 | 0.029 | 0.027 | ||
| Right | 51 | 1.259 | 0.152 | 100 | 1.213 | 0.079 | ||
| Left | 52 | 1.232 | 0.113 | 100 | 1.202 | 0.078 | 0.103 | |
| R–L | 49 | 0.031 | 0.13 | 99 | 0.011 | 0.066 | 0.314 | 0.19 |
| |R–L|* | 49 | 0.096 | 0.092 | 100 | 0.049 | 0.045 | ||
| Right | 51 | 1.081 | 0.045 | 100 | 1.078 | 0.036 | 0.63 | 0.08 |
| Left | 52 | 1.079 | 0.047 | 99 | 1.087 | 0.040 | 0.314 | − 0.17 |
| R–L | 49 | − 0.002 | 0.051 | 99 | 0.001 | 0.115 | 0.395 | 0.15 |
| |R–L|* | 49 | 0.037 | 0.034 | 99 | 0.031 | 0.032 | 0.557 | 0.16 |
| Right | 51 | 1.414 | 0.154 | 100 | 1.348 | 0.069 | ||
| Left | 52 | 1.372 | 0.099 | 99 | 1.342 | 0.066 | ||
| R–L | 49 | 0.039 | 0.119 | 99 | 0.008 | 0.051 | 0.079 | |
| |R–L|* | 49 | 0.091 | 0.085 | 99 | 0.039 | 0.034 | ||
| Right | 51 | 1.306 | 0.107 | 100 | 1.252 | 0.056 | ||
| Left | 52 | 1.271 | 0.067 | 100 | 1.235 | 0.059 | ||
| R–L | 49 | 0.037 | 0.092 | 100 | 0.017 | 0.050 | 0.168 | |
| |R–L|* | 49 | 0.066 | 0.074 | 100 | 0.038 | 0.036 | ||
| 49 | 0.375 | 0.248 | 99 | 0.213 | 0.142 | < 0.0001 | ||
| 49 | 0.143 | 0.092 | 99 | 0.068 | 0.046 | < 0.0001 | ||
Values of p and Cohen’s d are given for differences between patients and controls (t test). Negative d denotes lower values in patients compared to controls and positive d denotes higher values in patients compared to controls. All significant patient/control differences (in bold) involve digits 2D and 5D and all have positive values of d, i.e. patients > controls.
*Mann–Whitney test.
Differences in digit ratios and their asymmetries between patients and controls—(ANOVA) controlled for sex.
| Group | Sex | Group*sex (interaction) | ES** (ω2) | ||||
|---|---|---|---|---|---|---|---|
| F | p | F | p | F | p | ||
| 2.604 | 0.1087 | 1.354 | 0.246 | 0.683 | 0.410 | ||
| Left | 0.000 | 0.9845 | 1.224 | 0.270 | 1.421 | 0.235 | |
| R–L | 0.625 | 0.4306 | 0.569 | 0.452 | 1.253 | 0.265 | |
| |R–L| | 1.580 | 0.2107 | 0.352 | 0.554 | 1.659 | 0.200 | |
| 0.741 | 0.3908 | 0.008 | 0.930 | 0.086 | 0.770 | ||
| Left | 0.402 | 0.5272 | 1.210 | 0.273 | 1.223 | 0.270 | |
| R–L | 0.000 | 1.0000 | 1.562 | 0.213 | 1.106 | 0.295 | |
| |R–L| | 20.146 | 0.005 | 0.942 | 0.106 | 0.745 | ||
| |R–L|* | Z = 4.123; p < | ||||||
| 5.809 | 0.223 | 0.638 | 0.002 | 0.963 | 0.031 | ||
| Right * | Z = 1.639; p = 0.1013 | ||||||
| Left | 3.331 | 0.0700 | 2.303 | 0.131 | 0.550 | 0.459 | |
| R–L | 1.751 | 0.1878 | 1.436 | 0.233 | 0.883 | 0.349 | |
| |R–L| | 18.281 | 0.023 | 0.880 | 0.001 | 0.973 | ||
| |R–L|* | Z = 2.855; p = | ||||||
| 0.264 | 0.6080 | 1.140 | 0.287 | 0.225 | 0.636 | ||
| Left | 1.002 | 0.3186 | 0.019 | 0.891 | 0.031 | 0.861 | |
| R–L | 0.780 | 0.3785 | 0.333 | 0.565 | 0.034 | 0.854 | |
| |R–L| | 1.071 | 0.3024 | 4.133 | 1.299 | 0.256 | ||
| 12.908 | 0.000 | 0.997 | 0.108 | 0.744 | |||
| Right* | Z = 3.012; p = | ||||||
| Left | 5.010 | 1.308 | 0.255 | 0.000 | 0.994 | 0.029 | |
| Left* | Z = 1.189; p = 0.2346 | ||||||
| R–L | 5.334 | 0.811 | 0.369 | 0.101 | 0.751 | 0.026 | |
| R–L* | Z = 1.964; p = | ||||||
| |R–L| | 27.966 | 1.664 | 0.199 | 0.501 | 0.480 | ||
| |R–L|* | Z = 4.841; p | ||||||
| 16.564 | 0.555 | 0.457 | 0.001 | 0.970 | |||
| Right* | Z = 3.409; p = 0.0007 | ||||||
| Left | 11.712 | 1.161 | 0.283 | 0.001 | 0.978 | ||
| R–L | 2.850 | 0.0935 | 0.086 | 0.770 | 0.009 | 0.924 | |
| |R–L| | 9.575 | 1.071 | 0.302 | 0.120 | 0.730 | 0.055 | |
| |R–L|* | Z = 2.475; p = | ||||||
| 25.856 | 1.374 | 0.243 | 0.086 | 0.769 | |||
| Z = 4.494; p < | |||||||
| 44.888 | < | 1.162 | 0.283 | 0.217 | 0.642 | ||
| Z = 5.676; p < | |||||||
*non-parametric test (Mann–Whitney), ** effect size—ω2 , CA—Composite Asymmetry |Δ2D:3D| + |Δ2D:4D | + |Δ2D:5D| + |Δ3D:4D | + |Δ3D:5D| + |Δ4D:5D |, Clinical CA –|Δ2D:4D| + |Δ3D:5D| , bold—significant patient/control differences, medium/strong ES.
Figure 1Means (SE error bars) patient (P) and control (C) unsigned asymmetries (|right–left)|) for the digit ratios of 2D:3D; 2D:4D; 2D:5D; 3D:4D; 3D:5D and 4D:5D. Clinical composite asymmetry (Comp Asym) is (|right–left)|2D:4D + |right–left)| 3D:5D)/2.
Figure 2ROC curve for the clinical composite asymmetry predicting probability of hositalization due to Covid-19.